Categories: The Charlton Centre

Prevnar 20 Approved by Health Canada

Vaccination to prevent bacterial pneumonia is suggested for all patients with either a medical condition or immunosuppressive treatment that increases their infection risk. Before starting on advanced therapies such as biologics, we suggest adults update their vaccines, which includes pneumonia protection. Prevnar 13 is a vaccine protecting against the main 13 types of bacterial pneumonia and one dose lasts for a person’s whole life.

Health Canada has just approved Prevnar 20, which is already available in the United States. This will provide lifelong protection against an additional 7 types of pneumonia and will likely replace Prevnar 13. It should be available for purchase by the end of July. It is our hope that it will be publicly funded for compromised adults over 50 as Prevnar 13 is currently.

If you have received Prevnar 13 in the past, you may consider upgrading to this enhanced protection when it is made available to you as long as it has been at least 6 months from the previous Prevnar 13 dose.

Carolyn Whiskin is the Pharmacy Manager for Charlton Health. Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain, and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Share
Published by
admin

Recent Posts

Happy Back-to-School!

This week, many will return to school, and it's no secret that the back-to-school season…

1 week ago

Staying Hydrated in the Summer

Staying well hydrated is important in every season, but it becomes especially crucial during thesummer.…

3 weeks ago

World Hepatitis Day

Last week, on July 28th, we observed World Hepatitis Day, a day dedicated to raising…

1 month ago

Traveling This Summer with Biologics? Here’s What You Need to Know

Summer is a great time to get out and see new sights. Whether you're planning…

2 months ago

Summer Sun Safety

Now that the warmer weather is here, many of us are spending more time enjoying…

2 months ago

New Biosimilars of Xolair and Actemra Now Available: Omlyclo and Tyenne

Biosimilars are becoming more common in Canada, offering patients trusted alternatives to the originator biologic medication. Biosimilars…

3 months ago